Table of Content

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The growing awareness related to eye care diagnostics
4.1.1.2. The rising prevalence of retinal diseases amongst the geriatric population
4.1.2. Technological advances and the availability of new biomaterials
4.1.3. Restraints:
4.1.3.1. The growing acceptance of refractive surgeries
4.1.3.2. Complexities of prostheses implantation
4.1.4. Opportunity
4.1.5. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Type of Product
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Product
7.1.2. Market Attractiveness Index, By Type of Product
7.2. Contact Lenses*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.2.3. Therapeutic contact lenses *
7.2.4. Drug-eluting contact lenses
7.2.5. Diagnostic or monitoring contact lenses
7.3. Visual prostheses
7.3.1. Retinal Implant
7.3.2. Optic Nerve Implant
7.3.3. Cortical Implant
8. By Type of Diseases
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Diseases
8.1.2. Market Attractiveness Index, By Type of Diseases
8.2. Glaucoma*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Diabetes
8.4. AMD (Age-Related Macular Degeneration)
8.5. Retinitis pigmentosa
8.6. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Product
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Diseases
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Product
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Diseases
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. U.K.
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Product
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Diseases
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Product
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Diseases
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Product
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type of Diseases
10. Competitive Landscape
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Type Benchmarking
11. Company Profiles
11.1. Johnson & Johnson*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. NIDEK
11.3. Novartis
11.4. Second Sight
11.5. Bionic Sight
11.6. NJRetina
11.7. Interojo
11.8. Optobionics Corp
11.9. OcuMedic
LIST NOT EXHAUSTIVE
12. Global Next Generation Contact Lenses and Visual Prostheses Market – DataM
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us